Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SUMATRIPTAN\SUMATRIPTAN vs SUVOREXANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SUMATRIPTAN\SUMATRIPTAN vs SUVOREXANT: Safety Overview

Metric SUMATRIPTAN\SUMATRIPTAN SUVOREXANT
Total FAERS Reports 661 9,413
Deaths Reported 7 219
Death Rate 1.1% 2.3%
Hospitalizations 83 572
Average Patient Age 48.0 yrs 62.6 yrs
% Female Patients 88.6% 62.4%
FDA Approval Date N/A Aug 13, 2014
Manufacturer N/A Merck Sharp & Dohme LLC
Route N/A ORAL
Marketing Status N/A Prescription